Skip to main content
logo
Prestige BioPharma Limited (KRX:950210)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,580
-210 (-1.64%)
At close: Nov 14, 2025

Revenue by Product

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2019FY 2018
Period Ending
Jun '24 Jun '23 Jun '19 Jun '18
Anti-cancer Drugs
689.73M
Log In
Log In
Log In
Anti-cancer Drugs Growth
325.85%
Log In
Log In
Log In

Revenue by Geography

Millions KRW. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024FY 2023FY 2019FY 2018
Period Ending
Jun '24 Jun '23 Jun '19 Jun '18
Singapore
689.73M
Log In
Log In
Log In
Singapore Growth
325.85%
Log In
Log In
Log In
South Korea
-
Log In
Log In
Log In